1 Market Overview of Bio Similars/Subsequent Entry Biologic 1.1 Bio Similars/Subsequent Entry Biologic Market Overview 1.1.1 Bio Similars/Subsequent Entry Biologic Product Scope 1.1.2 Market Status and Outlook 1.2 Global Bio Similars/Subsequent Entry Biologic Market Size Overview by Region 2015 VS 2020 VS 2026 1.3 Global Bio Similars/Subsequent Entry Biologic Market Size by Region (2015-2026) 1.4 Global Bio Similars/Subsequent Entry Biologic Historic Market Size by Region (2015-2020) 1.5 Global Bio Similars/Subsequent Entry Biologic Market Size Forecast by Region (2021-2026) 1.6 Key Regions, Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2015-2026) 1.6.1 North America Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2015-2026) 1.6.2 Europe Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2015-2026) 1.6.3 Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2015-2026) 1.6.4 Latin America Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2015-2026) 1.6.5 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2015-2026) 2 Bio Similars/Subsequent Entry Biologic Market Overview by Type 2.1 Global Bio Similars/Subsequent Entry Biologic Market Size by Type: 2015 VS 2020 VS 2026 2.2 Global Bio Similars/Subsequent Entry Biologic Historic Market Size by Type (2015-2020) 2.3 Global Bio Similars/Subsequent Entry Biologic Forecasted Market Size by Type (2021-2026) 2.4 Monoclonal Antibodies 2.5 Interferon 2.6 Erythropoietin 2.7 Insulin 2.8 Vaccines 2.9 Other 3 Bio Similars/Subsequent Entry Biologic Market Overview by Application 3.1 Global Bio Similars/Subsequent Entry Biologic Market Size by Application: 2015 VS 2020 VS 2026 3.2 Global Bio Similars/Subsequent Entry Biologic Historic Market Size by Application (2015-2020) 3.3 Global Bio Similars/Subsequent Entry Biologic Forecasted Market Size by Application (2021-2026) 3.4 Tumor 3.5 Diabetes 3.6 Cardiovascular 3.7 Hemophilia 3.8 Other 4 Global Bio Similars/Subsequent Entry Biologic Competition Analysis by Players 4.1 Global Bio Similars/Subsequent Entry Biologic Market Size (Million US$) by Players (2015-2020) 4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bio Similars/Subsequent Entry Biologic as of 2019) 4.3 Date of Key Manufacturers Enter into Bio Similars/Subsequent Entry Biologic Market 4.4 Global Top Players Bio Similars/Subsequent Entry Biologic Headquarters and Area Served 4.5 Key Players Bio Similars/Subsequent Entry Biologic Product Solution and Service 4.6 Competitive Status 4.6.1 Bio Similars/Subsequent Entry Biologic Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Sun Pharma 5.1.1 Sun Pharma Profile 5.1.2 Sun Pharma Main Business 5.1.3 Sun Pharma Products, Services and Solutions 5.1.4 Sun Pharma Revenue (US$ Million) & (2015-2020) 5.1.5 Sun Pharma Recent Developments 5.2 Synthon Pharmaceuticals 5.2.1 Synthon Pharmaceuticals Profile 5.2.2 Synthon Pharmaceuticals Main Business and Company’s Total Revenue 5.2.3 Synthon Pharmaceuticals Products, Services and Solutions 5.2.4 Synthon Pharmaceuticals Revenue (US$ Million) (2015-2020) 5.2.5 Synthon Pharmaceuticals Recent Development and Reaction to Covid-19 5.3 Teva Pharmaceutical Industries 5.5.1 Teva Pharmaceutical Industries Profile 5.3.2 Teva Pharmaceutical Industries Main Business 5.3.3 Teva Pharmaceutical Industries Products, Services and Solutions 5.3.4 Teva Pharmaceutical Industries Revenue (US$ Million) & (2015-2020) 5.3.5 LG Life Sciences Recent Developments 5.4 LG Life Sciences 5.4.1 LG Life Sciences Profile 5.4.2 LG Life Sciences Main Business 5.4.3 LG Life Sciences Products, Services and Solutions 5.4.4 LG Life Sciences Revenue (US$ Million) & (2015-2020) 5.4.5 LG Life Sciences Recent Developments 5.5 Celltrion Biocon 5.5.1 Celltrion Biocon Profile 5.5.2 Celltrion Biocon Main Business 5.5.3 Celltrion Biocon Products, Services and Solutions 5.5.4 Celltrion Biocon Revenue (US$ Million) & (2015-2020) 5.5.5 Celltrion Biocon Recent Developments 5.6 Hospira 5.6.1 Hospira Profile 5.6.2 Hospira Main Business 5.6.3 Hospira Products, Services and Solutions 5.6.4 Hospira Revenue (US$ Million) & (2015-2020) 5.6.5 Hospira Recent Developments 5.7 Merck 5.7.1 Merck Profile 5.7.2 Merck Main Business and Company’s Total Revenue 5.7.3 Merck Products, Services and Solutions 5.7.4 Merck Revenue (US$ Million) (2015-2020) 5.7.5 Merck Recent Development and Reaction to Covid-19 5.8 Biogen idec 5.8.1 Biogen idec Profile 5.8.2 Biogen idec Main Business 5.8.3 Biogen idec Products, Services and Solutions 5.8.4 Biogen idec Revenue (US$ Million) & (2015-2020) 5.8.5 Biogen idec Recent Developments 5.9 Genentech (Roche) 5.9.1 Genentech (Roche) Profile 5.9.2 Genentech (Roche) Main Business 5.9.3 Genentech (Roche) Products, Services and Solutions 5.9.4 Genentech (Roche) Revenue (US$ Million) & (2015-2020) 5.9.5 Genentech (Roche) Recent Developments 5.10 Pfizer 5.10.1 Pfizer Profile 5.10.2 Pfizer Main Business 5.10.3 Pfizer Products, Services and Solutions 5.10.4 Pfizer Revenue (US$ Million) & (2015-2020) 5.10.5 Pfizer Recent Developments 5.11 Celltrion 5.11.1 Celltrion Profile 5.11.2 Celltrion Main Business 5.11.3 Celltrion Products, Services and Solutions 5.11.4 Celltrion Revenue (US$ Million) & (2015-2020) 5.11.5 Celltrion Recent Developments 5.12 Biocon 5.12.1 Biocon Profile 5.12.2 Biocon Main Business 5.12.3 Biocon Products, Services and Solutions 5.12.4 Biocon Revenue (US$ Million) & (2015-2020) 5.12.5 Biocon Recent Developments 5.13 Amgen 5.13.1 Amgen Profile 5.13.2 Amgen Main Business 5.13.3 Amgen Products, Services and Solutions 5.13.4 Amgen Revenue (US$ Million) & (2015-2020) 5.13.5 Amgen Recent Developments 5.14 Samsung Biologics 5.14.1 Samsung Biologics Profile 5.14.2 Samsung Biologics Main Business 5.14.3 Samsung Biologics Products, Services and Solutions 5.14.4 Samsung Biologics Revenue (US$ Million) & (2015-2020) 5.14.5 Samsung Biologics Recent Developments 5.15 Mylan 5.15.1 Mylan Profile 5.15.2 Mylan Main Business 5.15.3 Mylan Products, Services and Solutions 5.15.4 Mylan Revenue (US$ Million) & (2015-2020) 5.15.5 Mylan Recent Developments 5.16 Dr. Reddy's Laboratories 5.16.1 Dr. Reddy's Laboratories Profile 5.16.2 Dr. Reddy's Laboratories Main Business and Company’s Total Revenue 5.16.3 Dr. Reddy's Laboratories Products, Services and Solutions 5.16.4 Dr. Reddy's Laboratories Revenue (US$ Million) (2015-2020) 5.16.5 Dr. Reddy's Laboratories Recent Development and Reaction to Covid-19 5.17 Stada Arzneimittel AG 5.17.1 Stada Arzneimittel AG Profile 5.17.2 Stada Arzneimittel AG Main Business 5.17.3 Stada Arzneimittel AG Products, Services and Solutions 5.17.4 Stada Arzneimittel AG Revenue (US$ Million) & (2015-2020) 5.17.5 Stada Arzneimittel AG Recent Developments 5.18 AbbVie 5.18.1 AbbVie Profile 5.18.2 AbbVie Main Business 5.18.3 AbbVie Products, Services and Solutions 5.18.4 AbbVie Revenue (US$ Million) & (2015-2020) 5.18.5 AbbVie Recent Developments 5.19 Sanofi-Aventis 5.19.1 Sanofi-Aventis Profile 5.19.2 Sanofi-Aventis Main Business 5.19.3 Sanofi-Aventis Products, Services and Solutions 5.19.4 Sanofi-Aventis Revenue (US$ Million) & (2015-2020) 5.19.5 Sanofi-Aventis Recent Developments 5.20 Johnson & Johnson 5.20.1 Johnson & Johnson Profile 5.20.2 Johnson & Johnson Main Business 5.20.3 Johnson & Johnson Products, Services and Solutions 5.20.4 Johnson & Johnson Revenue (US$ Million) & (2015-2020) 5.20.5 Johnson & Johnson Recent Developments 5.21 Novo Nordisk 5.21.1 Novo Nordisk Profile 5.21.2 Novo Nordisk Main Business 5.21.3 Novo Nordisk Products, Services and Solutions 5.21.4 Novo Nordisk Revenue (US$ Million) & (2015-2020) 5.21.5 Novo Nordisk Recent Developments 5.22 Eli Lilly 5.22.1 Eli Lilly Profile 5.22.2 Eli Lilly Main Business 5.22.3 Eli Lilly Products, Services and Solutions 5.22.4 Eli Lilly Revenue (US$ Million) & (2015-2020) 5.22.5 Eli Lilly Recent Developments 5.23 Novartis 5.23.1 Novartis Profile 5.23.2 Novartis Main Business 5.23.3 Novartis Products, Services and Solutions 5.23.4 Novartis Revenue (US$ Million) & (2015-2020) 5.23.5 Novartis Recent Developments 5.24 3sbio 5.24.1 3sbio Profile 5.24.2 3sbio Main Business 5.24.3 3sbio Products, Services and Solutions 5.24.4 3sbio Revenue (US$ Million) & (2015-2020) 5.24.5 3sbio Recent Developments 5.25 Biotech 5.25.1 Biotech Profile 5.25.2 Biotech Main Business 5.25.3 Biotech Products, Services and Solutions 5.25.4 Biotech Revenue (US$ Million) & (2015-2020) 5.25.5 Biotech Recent Developments 5.26 Gelgen 5.26.1 Gelgen Profile 5.26.2 Gelgen Main Business 5.26.3 Gelgen Products, Services and Solutions 5.26.4 Gelgen Revenue (US$ Million) & (2015-2020) 5.26.5 Gelgen Recent Developments 5.27 Innovent 5.27.1 Innovent Profile 5.27.2 Innovent Main Business 5.27.3 Innovent Products, Services and Solutions 5.27.4 Innovent Revenue (US$ Million) & (2015-2020) 5.27.5 Innovent Recent Developments 5.28 Dong Bao 5.28.1 Dong Bao Profile 5.28.2 Dong Bao Main Business 5.28.3 Dong Bao Products, Services and Solutions 5.28.4 Dong Bao Revenue (US$ Million) & (2015-2020) 5.28.5 Dong Bao Recent Developments 5.29 Ganlee 5.29.1 Ganlee Profile 5.29.2 Ganlee Main Business 5.29.3 Ganlee Products, Services and Solutions 5.29.4 Ganlee Revenue (US$ Million) & (2015-2020) 5.29.5 Ganlee Recent Developments 6 North America 6.1 North America Bio Similars/Subsequent Entry Biologic Market Size by Country 6.2 United States 6.3 Canada 7 Europe 7.1 Europe Bio Similars/Subsequent Entry Biologic Market Size by Country 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size by Region 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America Bio Similars/Subsequent Entry Biologic Market Size by Country 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Country 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 Bio Similars/Subsequent Entry Biologic Market Dynamics 11.1 Industry Trends 11.2 Market Drivers 11.3 Market Challenges 11.4 Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market Bio Similars/Subsequent Entry Biologic Market Size (US$ Million) Comparison by Region 2015 VS 2020 VS 2026 Table 2. Global Bio Similars/Subsequent Entry Biologic Market Size by Region (2015-2020) (US$ Million) Table 3. Global Bio Similars/Subsequent Entry Biologic Market Size Share by Region (2015-2020) Table 4. Global Bio Similars/Subsequent Entry Biologic Forecasted Market Size by Region (2021-2026) (US$ Million) Table 5. Global Bio Similars/Subsequent Entry Biologic Forecasted Market Size Share by Region (2021-2026) Table 6. Global Bio Similars/Subsequent Entry Biologic Market Size (US$ Million) by Type: 2015 VS 2020 VS 2026 Table 7. Global Bio Similars/Subsequent Entry Biologic Market Size by Type (2015-2020) (US$ Million) Table 8. Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Type (2015-2020) Table 9. Global Bio Similars/Subsequent Entry Biologic Forecasted Market Size by Type (2021-2026) (US$ Million) Table 10. Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Type (2021-2026) Table 11. Global Bio Similars/Subsequent Entry Biologic Market Size (US$ Million) by Application: 2015 VS 2020 VS 2026 Table 12. Global Bio Similars/Subsequent Entry Biologic Market Size by Application (2015-2020) (US$ Million) Table 13. Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Application (2015-2020) Table 14. Global Bio Similars/Subsequent Entry Biologic Forecasted Market Size by Application (2021-2026) (US$ Million) Table 15. Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Application (2021-2026) Table 16. Global Bio Similars/Subsequent Entry Biologic Revenue (US$ Million) by Players (2015-2020) Table 17. Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Players (2015-2020) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bio Similars/Subsequent Entry Biologic as of 2019) Table 19. Date of Key Manufacturers Enter into Bio Similars/Subsequent Entry Biologic Market Table 20. Global Bio Similars/Subsequent Entry Biologic Top Players Headquarters and Area Served Table 21. Bio Similars/Subsequent Entry Biologic Product Solution and Service Table 22. Global Bio Similars/Subsequent Entry Biologic Manufacturers Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Sun Pharma Basic Information List Table 25. Sun Pharma Description and Business Overview Table 26. Sun Pharma Bio Similars/Subsequent Entry Biologic Products, Services and Solutions Table 27. Revenue (Million US$) in Bio Similars/Subsequent Entry Biologic Business of Sun Pharma (2015-2020) Table 28. Sun Pharma Recent Developments Table 29. Synthon Pharmaceuticals Basic Information List Table 30. Synthon Pharmaceuticals Description and Business Overview Table 31. Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Products, Services and Solutions Table 32. Revenue (Million US$) in Bio Similars/Subsequent Entry Biologic Business of Synthon Pharmaceuticals (2015-2020) Table 33. Synthon Pharmaceuticals Recent Developments Table 34. Teva Pharmaceutical Industries Basic Information List Table 35. Teva Pharmaceutical Industries Description and Business Overview Table 36. Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Products, Services and Solutions Table 37. Revenue (Million US$) in Bio Similars/Subsequent Entry Biologic Business of Teva Pharmaceutical Industries (2015-2020) Table 38. Teva Pharmaceutical Industries Recent Developments Table 39. LG Life Sciences Basic Information List Table 40. LG Life Sciences Description and Business Overview Table 41. LG Life Sciences Bio Similars/Subsequent Entry Biologic Products, Services and Solutions Table 42. Revenue (Million US$) in Bio Similars/Subsequent Entry Biologic Business of LG Life Sciences (2015-2020) Table 43. LG Life Sciences Recent Developments Table 44. Celltrion Biocon Basic Information List Table 45. Celltrion Biocon Description and Business Overview Table 46. Celltrion Biocon Bio Similars/Subsequent Entry Biologic Products, Services and Solutions Table 47. Revenue (Million US$) in Bio Similars/Subsequent Entry Biologic Business of Celltrion Biocon (2015-2020) Table 48. Celltrion Biocon Recent Developments Table 49. Hospira Basic Information List Table 50. Hospira Description and Business Overview Table 51. Hospira Bio Similars/Subsequent Entry Biologic Products, Services and Solutions Table 52. Revenue (Million US$) in Bio Similars/Subsequent Entry Biologic Business of Hospira (2015-2020) Table 53. Hospira Recent Developments Table 54. Merck Basic Information List Table 55. Merck Description and Business Overview Table 56. Merck Bio Similars/Subsequent Entry Biologic Products, Services and Solutions Table 57. Revenue (Million US$) in Bio Similars/Subsequent Entry Biologic Business of Merck (2015-2020) Table 58. Merck Recent Developments Table 59. Biogen idec Basic Information List Table 60. Biogen idec Description and Business Overview Table 61. Biogen idec Bio Similars/Subsequent Entry Biologic Products, Services and Solutions Table 62. Revenue (Million US$) in Bio Similars/Subsequent Entry Biologic Business of Biogen idec (2015-2020) Table 63. Biogen idec Recent Developments Table 64. Genentech (Roche) Basic Information List Table 65. Genentech (Roche) Description and Business Overview Table 66. Genentech (Roche) Bio Similars/Subsequent Entry Biologic Products, Services and Solutions Table 67. Revenue (Million US$) in Bio Similars/Subsequent Entry Biologic Business of Genentech (Roche) (2015-2020) Table 68. Genentech (Roche) Recent Developments Table 69. Pfizer Basic Information List Table 70. Pfizer Description and Business Overview Table 71. Pfizer Bio Similars/Subsequent Entry Biologic Products, Services and Solutions Table 72. Revenue (Million US$) in Bio Similars/Subsequent Entry Biologic Business of Pfizer (2015-2020) Table 73. Pfizer Recent Developments Table 74. Celltrion Basic Information List Table 75. Celltrion Description and Business Overview Table 76. Celltrion Bio Similars/Subsequent Entry Biologic Products, Services and Solutions Table 77. Revenue (Million US$) in Bio Similars/Subsequent Entry Biologic Business of Celltrion (2015-2020) Table 78. Celltrion Recent Developments Table 79. Biocon Basic Information List Table 80. Biocon Description and Business Overview Table 81. Biocon Bio Similars/Subsequent Entry Biologic Products, Services and Solutions Table 82. Revenue (Million US$) in Bio Similars/Subsequent Entry Biologic Business of Biocon (2015-2020) Table 83. Biocon Recent Developments Table 84. Amgen Basic Information List Table 85. Amgen Description and Business Overview Table 86. Amgen Bio Similars/Subsequent Entry Biologic Products, Services and Solutions Table 87. Revenue (Million US$) in Bio Similars/Subsequent Entry Biologic Business of Amgen (2015-2020) Table 88. Amgen Recent Developments Table 89. Samsung Biologics Basic Information List Table 90. Samsung Biologics Description and Business Overview Table 91. Samsung Biologics Bio Similars/Subsequent Entry Biologic Products, Services and Solutions Table 92. Revenue (Million US$) in Bio Similars/Subsequent Entry Biologic Business of Samsung Biologics (2015-2020) Table 93. Samsung Biologics Recent Developments Table 94. Mylan Basic Information List Table 95. Mylan Description and Business Overview Table 96. Mylan Bio Similars/Subsequent Entry Biologic Products, Services and Solutions Table 97. Revenue (Million US$) in Bio Similars/Subsequent Entry Biologic Business of Mylan (2015-2020) Table 98. Mylan Recent Developments Table 99. Dr. Reddy's Laboratories Basic Information List Table 100. Dr. Reddy's Laboratories Description and Business Overview Table 101. Dr. Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Products, Services and Solutions Table 102. Revenue (Million US$) in Bio Similars/Subsequent Entry Biologic Business of Dr. Reddy's Laboratories (2015-2020) Table 103. Dr. Reddy's Laboratories Recent Developments Table 104. Stada Arzneimittel AG Basic Information List Table 105. Stada Arzneimittel AG Description and Business Overview Table 106. Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Products, Services and Solutions Table 107. Revenue (Million US$) in Bio Similars/Subsequent Entry Biologic Business of Stada Arzneimittel AG (2015-2020) Table 108. Stada Arzneimittel AG Recent Developments Table 109. AbbVie Basic Information List Table 110. AbbVie Description and Business Overview Table 111. AbbVie Bio Similars/Subsequent Entry Biologic Products, Services and Solutions Table 112. Revenue (Million US$) in Bio Similars/Subsequent Entry Biologic Business of AbbVie (2015-2020) Table 113. AbbVie Recent Developments Table 114. Sanofi-Aventis Basic Information List Table 115. Sanofi-Aventis Description and Business Overview Table 116. Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Products, Services and Solutions Table 117. Revenue (Million US$) in Bio Similars/Subsequent Entry Biologic Business of Sanofi-Aventis (2015-2020) Table 118. Sanofi-Aventis Recent Developments Table 119. Johnson & Johnson Basic Information List Table 120. Johnson & Johnson Description and Business Overview Table 121. Johnson & Johnson Bio Similars/Subsequent Entry Biologic Products, Services and Solutions Table 122. Revenue (Million US$) in Bio Similars/Subsequent Entry Biologic Business of Johnson & Johnson (2015-2020) Table 123. Johnson & Johnson Recent Developments Table 124. Novo Nordisk Basic Information List Table 125. Novo Nordisk Description and Business Overview Table 126. Novo Nordisk Bio Similars/Subsequent Entry Biologic Products, Services and Solutions Table 127. Revenue (Million US$) in Bio Similars/Subsequent Entry Biologic Business of Novo Nordisk (2015-2020) Table 128. Novo Nordisk Recent Developments Table 129. Eli Lilly Basic Information List Table 130. Eli Lilly Description and Business Overview Table 131. Eli Lilly Bio Similars/Subsequent Entry Biologic Products, Services and Solutions Table 132. Revenue (Million US$) in Bio Similars/Subsequent Entry Biologic Business of Eli Lilly (2015-2020) Table 133. Eli Lilly Recent Developments Table 134. Novartis Basic Information List Table 135. Novartis Description and Business Overview Table 136. Novartis Bio Similars/Subsequent Entry Biologic Products, Services and Solutions Table 137. Revenue (Million US$) in Bio Similars/Subsequent Entry Biologic Business of Novartis (2015-2020) Table 138. Novartis Recent Developments Table 139. 3sbio Basic Information List Table 140. 3sbio Description and Business Overview Table 141. 3sbio Bio Similars/Subsequent Entry Biologic Products, Services and Solutions Table 142. Revenue (Million US$) in Bio Similars/Subsequent Entry Biologic Business of 3sbio (2015-2020) Table 143. 3sbio Recent Developments Table 144. Biotech Basic Information List Table 145. Biotech Description and Business Overview Table 146. Biotech Bio Similars/Subsequent Entry Biologic Products, Services and Solutions Table 147. Revenue (Million US$) in Bio Similars/Subsequent Entry Biologic Business of Biotech (2015-2020) Table 148. Biotech Recent Developments Table 149. Gelgen Basic Information List Table 150. Gelgen Description and Business Overview Table 151. Gelgen Bio Similars/Subsequent Entry Biologic Products, Services and Solutions Table 152. Revenue (Million US$) in Bio Similars/Subsequent Entry Biologic Business of Gelgen (2015-2020) Table 153. Gelgen Recent Developments Table 154. Innovent Basic Information List Table 155. Innovent Description and Business Overview Table 156. Innovent Bio Similars/Subsequent Entry Biologic Products, Services and Solutions Table 157. Revenue (Million US$) in Bio Similars/Subsequent Entry Biologic Business of Innovent (2015-2020) Table 158. Innovent Recent Developments Table 159. Dong Bao Basic Information List Table 160. Dong Bao Description and Business Overview Table 161. Dong Bao Bio Similars/Subsequent Entry Biologic Products, Services and Solutions Table 162. Revenue (Million US$) in Bio Similars/Subsequent Entry Biologic Business of Dong Bao (2015-2020) Table 163. Dong Bao Recent Developments Table 164. Ganlee Basic Information List Table 165. Ganlee Description and Business Overview Table 166. Ganlee Bio Similars/Subsequent Entry Biologic Products, Services and Solutions Table 167. Revenue (Million US$) in Bio Similars/Subsequent Entry Biologic Business of Ganlee (2015-2020) Table 168. Ganlee Recent Developments Table 169. North America Bio Similars/Subsequent Entry Biologic Market Size by Country (2015-2020) & (US$ Million) Table 170. North America Bio Similars/Subsequent Entry Biologic Market Size Share by Country (2015-2020) Table 171. Europe Bio Similars/Subsequent Entry Biologic Market Size by Country (2015-2020) & (US$ Million) Table 172. Europe Bio Similars/Subsequent Entry Biologic Market Size Share by Country (2015-2020) Table 173. Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size by Country (2015-2020) & (US$ Million) Table 174. Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size Share by Country (2015-2020) (US$ Million) Table 175. Latin America Bio Similars/Subsequent Entry Biologic Market Size by Country (2015-2020) & (US$ Million) Table 176. Latin America Bio Similars/Subsequent Entry Biologic Market Size Share by Country (2015-2020) (US$ Million) Table 177. Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Players (2015-2020) (US$ Million) Table 178. Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size Share by Players (2015-2020) (US$ Million) Table 179. Bio Similars/Subsequent Entry Biologic Market Trends Table 180. Bio Similars/Subsequent Entry Biologic Market Drivers Table 181. Bio Similars/Subsequent Entry Biologic Market Challenges Table 182. Bio Similars/Subsequent Entry Biologic Market Restriants Table 183. Research Programs/Design for This Report Table 184. Key Data Information from Secondary Sources Table 185. Key Data Information from Primary Sources List of Figures Figure 1. Global Bio Similars/Subsequent Entry Biologic Market Size Year-over-Year 2015-2026 & (US$ Million) Figure 2. Global Bio Similars/Subsequent Entry Biologic Market Size (US$ Million), 2015 VS 2020VS 2026 Figure 3. Global Bio Similars/Subsequent Entry Biologic Market Share by Regions: 2020 VS 2026 Figure 4. North America Bio Similars/Subsequent Entry Biologic Market Size (US$ Million) Growth Rate (2015-2026) Figure 5. Europe Bio Similars/Subsequent Entry Biologic Market Size (US$ Million) and Growth Rate (2015-2026) Figure 6. Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size (US$ Million) and Growth Rate (2015-2026) Figure 7. Latin America Bio Similars/Subsequent Entry Biologic Market Size (US$ Million) and Growth Rate (2015-2026) Figure 8. Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size (US$ Million) and Growth Rate (2015-2026) Figure 9. Global Bio Similars/Subsequent Entry Biologic Market Share by Type in 2020 & 2026 Figure 10. Monoclonal Antibodies Market Size (US$ Million) YoY Growth (2015-2026) Figure 11. Interferon Market Size (US$ Million) YoY Growth (2015-2026) Figure 12. Erythropoietin Market Size (US$ Million) YoY Growth (2015-2026) Figure 13. Insulin Market Size (US$ Million) YoY Growth (2015-2026) Figure 14. Vaccines Market Size (US$ Million) YoY Growth (2015-2026) Figure 15. Other Market Size (US$ Million) YoY Growth (2015-2026) Figure 16. Global Bio Similars/Subsequent Entry Biologic Market Size Share by Application in 2020 & 2026 Figure 17. Tumor Market Size (US$ Million) YoY Growth (2015-2026) Figure 18. Diabetes Market Size (US$ Million) YoY Growth (2015-2026) Figure 19. Cardiovascular Market Size (US$ Million) YoY Growth (2015-2026) Figure 20. Hemophilia Market Size (US$ Million) YoY Growth (2015-2026) Figure 21. Other Market Size (US$ Million) YoY Growth (2015-2026) Figure 22. Bio Similars/Subsequent Entry Biologic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 23. Global Top 5 and Top 10 Players Bio Similars/Subsequent Entry Biologic Market Share in 2019 Figure 24. United States Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 25. Canada Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 26. Germany Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 27. France Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 28. U.K. Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 29. Italy Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 30. Russia Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 31. Nordic Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 32. Rest of Europe Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 33. China Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 34. Japan Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 35. South Korea Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 36. Southeast Asia Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 37. India Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 38. Australia Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 39. Rest of Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 40. Mexico Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 41. Brazil Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 42. Rest of Latin America Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 43. Turkey Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 44. Saudi Arabia Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 45. UAE Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 46. Rest of Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 47. Bottom-up and Top-down Approaches for This Report Figure 48. Data Triangulation

Sun Pharma Synthon Pharmaceuticals Teva Pharmaceutical Industries LG Life Sciences Celltrion Biocon Hospira Merck Biogen idec Genentech (Roche) Pfizer Celltrion Biocon Amgen Samsung Biologics Mylan Dr. Reddy's Laboratories Stada Arzneimittel AG AbbVie Sanofi-Aventis Johnson & Johnson Novo Nordisk Eli Lilly Novartis 3sbio Biotech Gelgen Innovent Dong Bao Ganlee